N-acetylglutamate synthetase deficiency1 |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
N-acetyltransferase 2 deficiency |
|
|
|
N-acetyltransferase 2 deficiency |
NAT2 |
NAT2 |
2-3 |
autoimmune, type 1 |
AIRE |
AIRE |
2 - 4 |
autoimmune, type 1 |
|
|
2 - 4 |
nail dysplasia, congenital |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
Nail-Patella syndrome1,3 |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
NDH syndrome |
GLIS3 |
GLIS3 |
2-4 |
nemaline myopathy |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
neoplasia, multiple endocrine |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
neoplasie, multiple endocrine |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
neoplasm, myeloproliferative* |
|
|
|
- |
PDGFRB |
PDGFRB |
3-4 |
- |
PRV1 |
PRV1 |
NULL |
- |
JAK2, Exon 14, V617F |
JAK2, Exon 14, V617F |
1-2 |
- |
JAK2 |
JAK2 |
1-2 |
- |
MPL |
MPL |
1-2 |
NGS |
JAK2, CALR, MPL |
JAK2, CALR, MPL |
2 |
NGS |
JAK2, CALR, MPL, ASXL1, CBL, DNMT3A, EZH2, IDH1, IDH2, RUNX1, SF3B1, SRSF2, TET2, TP53, ZRSR2 |
JAK2, CALR, MPL, ASXL1, CBL, DNMT3A, EZH2, IDH1, IDH2, RUNX1, SF3B1, SRSF2, TET2, TP53, ZRSR2 |
2 |
Nephroblastoma (NGS) |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
Nephronophthisis1,2,3 |
|
|
|
NPHP1 |
NPHP1 |
NPHP1 |
2-5 |
NPHP1 |
NPHP1 |
NPHP1 |
2-3 |
nephrotic syndrome (NGS) |
PLCE1, TRPC6, ACTN4, WT1, SMARCAL1, LAMB2, ITGB4, COQ2, CO |
PLCE1,TRPC6,ACTN4,WT1,SMARCAL1,LAMB2,ITGB4,COQ2,CO |
4-6 |
nephrotic syndrome1,3 |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
Netherton syndrome |
SPINK5 |
SPINK5 |
4-5 |
neuroblastoma |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |
FLNB |
FLNB |
5-6 |
NGS |
FLNB |
FLNB |
3-4 |
amyotrophic |
KIF5A |
KIF5A |
3-4 |
amyotrophic |
SOD1 |
SOD1 |
3-4 |
amyotrophic 14 |
VCP |
VCP |
2-6 |
Type 2 |
ALS2 |
ALS2 |
1-9 / 100 000 |
|
BRPF1 |
BRPF1 |
NULL |
|
GABRB3 |
GABRB3 |
2-4 |
Leopard syndrome |
PTPN11 |
PTPN11 |
3-4 |
- |
CEBPA |
CEBPA |
2 |
- |
CALM-AF10 |
CALM-AF10 |
2 |
- |
CBFB-MYH11 |
CBFB-MYH11 |
2 |
- |
DEK-CAN |
DEK-CAN |
2 |
- |
CBL |
CBL |
2 |
- |
FLT3 |
FLT3 |
2 |
- |
IDH1 |
IDH1 |
2 |
- |
IDH2 |
IDH2 |
2 |
- |
KIT |
KIT |
2 |
- |
KMT2A-ELL |
KMT2A-ELL |
2 |
- |
KMT2A-MLLT1 |
KMT2A-MLLT1 |
2 |
- |
KMT2A-MLLT3 |
KMT2A-MLLT3 |
2 |
- |
KMT2A-MLLT4 |
KMT2A-MLLT4 |
2 |
- |
KRAS |
KRAS |
2 |
- |
MLL-PTD/KMT2A-PTD |
MLL-PTD/KMT2A-PTD |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1 |
NPM1 |
2 |
- |
NPM1-MLF1 |
NPM1-MLF1 |
2 |
- |
RUNX1 |
RUNX1 |
2 |
- |
TET2 |
TET2 |
2 |
- |
WT1 |
WT1 |
2 |
- |
RUNX1-RUNX1T1 |
RUNX1-RUNX1T1 |
2 |
NGS |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 |
ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP |
2 |
- |
FLT3-ITD |
FLT3-ITD |
2-3 |
qualitative |
PML-RARA |
PML-RARA |
1 |
quantitative |
PML-RARA |
PML-RARA |
1-2 |
NGS |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 |
ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, |
2 |
NGS |
CSF3R, SETBP1, ASXL1 |
CSF3R, SETBP1, ASXL1 |
2 |
NGS |
CBL, NRAS, KRAS, PTPN11 |
CBL, NRAS, KRAS, PTPN11 |
2 |
- |
DNMT3A |
DNMT3A |
2 |
- |
NRAS |
NRAS |
2 |
NGS |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 |
2 |
|
ITGB2, SLC35C1, FERMT3 |
ITGB2, SLC35C1, FERMT3 |
4-6 |
Type 1 |
ITGB2 |
ITGB2 |
2-4 |
Type 3 |
FERMT3 |
FERMT3 |
2-4 |
NGS |
LEUK |
LEUK |
|
quantitative |
BCR-ABL1 p190/e1a2 |
BCR-ABL1 p190/e1a2 |
1-2 |
|
CEBPA, FLT3-ITD, cKIT, NPM1 |
CEBPA, FLT3-ITD, cKIT, NPM1 |
NULL |
Li-Fraumeni syndrome |
TP53 |
TP53 |
2-4 |
Li-Fraumeni syndrome |
TP53 |
TP53 |
4-6 |
NGS |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... |
ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, |
4-6 |
|
FKTN |
FKTN |
2-4 |
linear skin defects with multiple congenital anoma |
COX7B |
COX7B |
3-4 |
linear skin defects with multiple congenital anoma |
HCCS |
HCCS |
3-4 |
- |
PPARG |
PPARG |
2-4 |
- |
LMNB2 |
LMNB2 |
2-4 |
type 1 |
LIS1/PAFAH1B1 |
LIS1/PAFAH1B1 |
4-5 |
type 2 |
RELN |
RELN |
8-12 |
X-linked |
DCX |
DCX |
8-9 |
|
TUBA1A |
TUBA1A |
NULL |
|
SCN5A |
SCN5A |
NULL |
|
CALM2 |
CALM2 |
NULL |
LQT1 |
KCNQ1 |
KCNQ1 |
2-4 |
LQT1, LQT2, LQT5, LQT6 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
KCNQ1, KCNH2, KCNE1, KCNE2 |
2-4 |
LQT10 |
SCN4B |
SCN4B |
2-4 |
LQT2 |
KCNH2 |
KCNH2 |
2-4 |
LQT5 |
KCNE1 |
KCNE1 |
2-4 |
LQT6 |
KCNE2 |
KCNE2 |
2-4 |
LQT7 |
KCNJ2 |
KCNJ2 |
2-4 |
NGS |
CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 |
CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 |
4-6 |
type 3 |
SCN5A |
SCN5A |
2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency |
HADHA |
HADHA |
4-8 |
|
CACNA1C |
CACNA1C |
|
Lowe syndrome |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
hemophagocytic |
PRF1, STX11, UNC13D |
PRF1,STX11, UNC13D |
2-4 |
hemophagocytic, type 2 |
PRF1 |
PRF1 |
4-8 |
hemophagocytic, type 3 |
UNC13D |
UNC13D |
4-8 |
hemophagocytic, type 4 |
STX11 |
STX11 |
4-8 |
hemophagocytic, type 5 |
STXBP2 |
STXBP2 |
4-8 |
NGS |
PRF1, UNC13D, STX11, STXBP2 |
PRF1, UNC13D, STX11, STXBP2 |
4-8 |
NGS |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 |
2 |
X-linked |
XIAP |
XIAP |
3-4 |
|
PDE11A |
PDE11A |
2-4 |
- |
MPDZ |
MPDZ |
2-4 |
|
CDH1 |
CDH1 |
|
|
|
|
4-8 |
|
|
|
NULL |
NGS |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... |
AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, |
4-6 |
|
KCNT1 |
KCNT1 |
NULL |
|
MLYCD |
MLYCD |
2-4 |
NGS |
BCKDHA, BCKDHB, DBT, DLD |
BCKDHA, BCKDHB, DBT, DLD |
4-6 |
type 1A |
BCKDHA |
BCKDHA |
2-4 |
type 1B |
BCKDHB |
BCKDHB |
2-4 |
type 2 |
DBT |
DBT |
2-4 |
Marden-Walker syndrome |
PIEZO2 |
PIEZO2 |
8-12 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
Marfan syndrome |
FBN1 |
FBN1 |
2-4 |
NGS |
FBN1, TGFBR1, TGFBR2 |
FBN1,TGFBR1,TGFBR2 |
4-6 |
NGS |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 |
2 |
NGS |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 |
2 |
|
GNAS |
GNAS |
4-6 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency |
ACADM |
ACADM |
2-4 |
|
AKT3 |
AKT3 |
NULL |
Meier-Gorlin syndrome 1 |
ORC1 |
ORC1 |
7-8 |
MELAS syndrome |
MT-TL1 |
MT-TL1 |
2-4 |
Menke disease |
ATP7A |
ATP7A |
3-4 |
|
CLTC |
CLTC |
|
|
DLG4 |
DLG4 |
|
MERRF syndrome |
MTTK |
MTTK |
2-4 |
metachromatic leucodystrophy |
ARSA |
ARSA |
4-6 |
|
|
|
1-2 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
2-4 |
type 1 and 2 |
CYB5R3 |
CYB5R3 |
4-8 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblC |
MMACHC |
MMACHC |
2-4 |
cblD |
MMADHC |
MMADHC |
2-4 |
methylmalonyl-CoA mutase deficiency |
MMUT |
MMUT |
6-8 |
sequence analysis MMUT |
MMUT |
MMUT |
2-4 |
|
NSUN2 |
NSUN2 |
6-10 |
|
SLC25A22 |
SLC25A22 |
2-4 |
|
SUOX |
SUOX |
3-5 |
|
LIG4 |
LIG4 |
4-6 |
|
|
|
4-8 |
- |
CEP63 |
CEP63 |
3-5 |
- |
IER3IP1 |
IER3IP1 |
3-5 |
- |
KIF11 |
KIF11 |
3-5 |
- |
MYO16 |
MYO16 |
3-5 |
- |
PCNT |
PCNT |
3-5 |
- |
RBBP8 |
RBBP8 |
4-6 |
- |
RTTN |
RTTN |
3-5 |
- |
SLC25A19 |
SLC25A19 |
3-5 |
- |
TRAPPC9 |
TRAPPC9 |
3-5 |
- |
TUBB2B |
TUBB2B |
3-5 |
MCPH1 |
MCPH1 |
MCPH1 |
3-5 |
MCPH2 |
WDR62 |
WDR62 |
3-5 |
MCPH3 |
CDK5RAP2 |
CDK5RAP2 |
3-5 |
MCPH4 |
CASC5 |
CASC5 |
3-5 |
MCPH4, MCPH9 |
CEP152 |
CEP152 |
3-5 |
MCPH5 |
ASPM |
ASPM |
3-5 |
MCPH6 |
CENPJ |
CENPJ |
3-5 |
MCPH8 |
CEP135 |
CEP135 |
5-7 |
Seckel syndrome |
ATR |
ATR |
3-5 |
- |
PLK4 |
PLK4 |
2-4 |
microvillus inclusion disease |
MYO5B |
MYO5B |
9-10 |
familial hemiplegic |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
ATP1A2, CACNA1A, NOTCH3, SCN1A |
4-8 |
familial hemiplegic 2 |
ATP1A2 |
ATP1A2 |
8-10 |
familial hemiplegic 3 |
SCN1A |
SCN1A |
4-5 |
familial hemiplegic type 1 |
CACNA1A |
CACNA1A |
4-6 |
|
|
|
4-8 |
|
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 |
2-4 |
|
QARS |
QARS |
NULL |
NGS |
MLH1, MSH2, MSH6, PMS2 |
MLH1, MSH2, MSH6, PMS2 |
4-8 |
|
MITF |
MITF |
3-4 |
NGS |
MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY |
MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR |
4-6 |
MNGIE syndrome |
TYMP, POLG, MGME1, RRM2B |
TYMP, POLG, MGME1, RRM2B |
4-6 |
MNGIE syndrome |
TYMP |
TYMP |
2-4 |
MLPA |
HNF1A, GCK, HNF4A und HNF1ß |
HNF1A, GCK, HNF4A und HNF1ß |
2-4 |
MLPA |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS |
2-4 |
NGS |
HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 |
HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 |
4-6 |
type 1 |
HNF4A |
HNF4A |
2-4 |
type 11 |
BLK |
BLK |
2-4 |
type 14 |
APPL1 |
APPL1 |
2-4 |
type 2 |
GCK |
GCK |
2-4 |
type 3 |
HNF1A |
HNF1A |
2-4 |
type 4 |
IPF1/PDX1 |
IPF1/PDX1 |
2-4 |
type 5 |
HNF1B |
HNF1B |
2-4 |
type 6 |
NEUROD1 |
NEUROD1 |
4-6 |
type 7 |
KLF11 |
KLF11 |
2-4 |
type 8 |
CEL |
CEL |
2-4 |
type 9 |
PAX4 |
PAX4 |
2-4 |
|
|
|
|
|
|
|
4-8 |
type A |
MOCS1 |
MOCS1 |
9-10 |
type B |
MOCS2 |
MOCS2 |
9-10 |
type C |
GPHN |
GPHN |
4-8 |
NGS |
AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 |
AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 |
4-8 |
- |
CXCR4 |
CXCR4 |
2 |
- |
MYD88 |
MYD88 |
2 |
NGS |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
MYD88, CXCR4, ARID1A, KMT2D (MLL2) |
2 |
mosaic variegated aneuploidy syndrome 1 |
BUB1B |
BUB1B |
4-6 |
Mowat-Wilson syndrome |
ZEB2/ZFHX1B |
ZEB2/ZFHX1B |
5-6 |
NGS |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH |
4-6 |
type 1H |
IDUA |
IDUA |
4-6 |
type 3A |
SGSH |
SGSH |
2-4 |
type 3B |
NAGLU |
NAGLU |
2-4 |
type 3C |
HGSNAT |
HGSNAT |
2-4 |
type 4A |
GALNS |
GALNS |
2-4 |
type 4B |
GLB1 |
GLB1 |
2-4 |
type 6 |
ARSB |
ARSB |
2-4 |
type 7 |
GUSB |
GUSB |
2-4 |
Muenke syndrome |
FGFR3 |
FGFR3 |
1-2 |
|
CFTR |
CFTR |
2-4 |
|
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS |
PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS |
2-4 |
muscle eye brain syndrome |
POMGNT1 |
POMGNT1 |
5-6 |
|
DYSF |
DYSF |
2 |
congenital |
LAMA2 |
LAMA2 |
8-10 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
Duchenne / Becker |
DMD |
DMD |
4-6 |
Duchenne / Becker |
DMD |
DMD |
2-4 |
|
RAPSN |
RAPSN |
NULL |
|
SLC5A7 |
SLC5A7 |
NULL |
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
myoclonus-dystonia syndrome |
SGCE |
SGCE |
6-8 |
genetic recurrent |
LPIN1 |
LPIN1 |
2-4 |
|
CLCN2 |
CLCN2 |
NULL |
|
SEPN1 |
SEPN1 |
3-4 |
distal |
ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP |
ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM |
4-8 |
metabolic |
AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere |
AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere |
4-8 |
NGS |
verschiedene Gene für MYOP |
verschiedene Gene für MYOP |
4-8 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
Becker, Thomsen |
CLCN1 |
CLCN1 |
2-4 |
|
MYT1L |
MYT1L |
NULL |
N-acetylglutamate synthetase deficiency |
NAGS |
NAGS |
2-4 |
|
DCHS2 |
DCHS2 |
NULL |
|
HGFAC |
HGFAC |
NULL |
|
KRTAP5-4 |
KRTAP5-4 |
NULL |
|
NRK |
NRK |
NULL |
|
PDE4C |
PDE4C |
NULL |
|
PLXNB1 |
PLXNB1 |
NULL |
|
PRDM9 |
PRDM9 |
NULL |
|
SLC5A8 |
SLC5A8 |
NULL |
|
STAG2 |
STAG2 |
NULL |
|
SUSD4 |
SUSD4 |
NULL |
|
ZNFX1 |
ZNFX1 |
NULL |
|
NQO1 |
NQO1 |
2-3 |
nail dysplasia, congenital |
FZD6 |
FZD6 |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
3-4 |
Nail-Patella syndrome |
LMX1B |
LMX1B |
2-3 |
- |
KLHL41 |
KLHL41 |
4-6 |
Amish type |
TNNT1 |
TNNT1 |
4-5 |
MEN2A |
RET |
RET |
3-4 |
NGS |
RET, MEN1, CDKN1B |
RET, MEN1, CDKN1B |
4-8 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 1 |
MEN1 |
MEN1 |
3-4 |
type 4 |
CDKN1B |
CDKN1B |
3-4 |
MEN2B |
RET |
RET |
3-4 |
NGS |
|
|
4-8 |
- |
OSGEP |
OSGEP |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
- |
MAGI2 |
MAGI2 |
2-4 |
NPHS1 |
NPHS1 |
NPHS1 |
2-4 |
NPHS2 |
NPHS2 |
NPHS2 |
2-4 |
NPHS4 |
WT1 |
WT1 |
1-2 |
NGS |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 |
4-8 |
neuromyotonia and axonal neuropathy |
HINT1 |
HINT1 |
6-8 |
neuronal ceroid lipofuscinosis |
ATP13A2 |
ATP13A2 |
5-6 |
|
ATL3 |
ATL3 |
NULL |
autosomal recessive |
OTOF |
OTOF |
4-6 |
NGS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
ELANE, G6PC3, HAX1, JAGN1, WAS |
4-8 |
severe congenital 1 |
ELANE/ELA2 |
ELANE/ELA2 |
2-4 |
severe congenital 3 |
HAX1 |
HAX1 |
4-6 |
severe congenital 4 |
G6PC3 |
G6PC3 |
4-8 |
severe congenital 6 |
JAGN1 |
JAGN1 |
4-8 |
somatic mutations |
CSF3R, TP53 |
CSF3R, TP53 |
2 |
X-linked |
WAS |
WAS |
4-8 |
|
NFE2L3 |
NFE2L3 |
NULL |
|
|
|
1-2 |
type C2 |
NPC2 |
NPC2 |
4-6 |
type C2 |
NPC2 |
NPC2 |
4-6 |
NGS |
|
|
4-6 Wochen |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
Nijmegen breakage syndrome |
NBN |
NBN |
4-5 |
|
PNPLA3 |
PNPLA3 |
1-2 |
non-ketotic hyperglycinemia |
GCSH |
GCSH |
3-4 |
|
GNE |
GNE |
NULL |
- |
BRAF |
BRAF |
3-4 |
- |
LZTR1 |
LZTR1 |
2-4 |
- |
PTPN11 |
PTPN11 |
3-4 |
- |
RAF1 |
RAF1 |
3-4 |
- |
RIT1 |
RIT1 |
2-4 |
- |
SOS1 |
SOS1 |
3-4 |
- |
CBL |
CBL |
2-4 |
- |
A2ML1 |
A2ML1 |
2-4 |
- |
SHOC2 |
SHOC2 |
3-4 |
9 |
SOS2 |
SOS2 |
3-4 |
NGS |
PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom |
PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom |
4-8 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
verschiedene Gene für NYS |
verschiedene Gene für NYS |
4-8 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 1 |
FRMD7 |
FRMD7 |
2-4 |
type 6 |
GPR143 |
GPR143 |
2-4 |
|
CHRNA4 |
CHRNA4 |
NULL |
|
LRIG2 |
LRIG2 |
NULL |
oculopharyngeal muscular dystrophy |
PABPN1 |
PABPN1 |
6-8 |
|
MID1 |
MID1 |
NULL |
ornithine transcarbamylase deficiency |
OTC |
OTC |
5-8 |
ornithine transcarbamylase deficiency |
OTC |
OTC |
3-4 |
|
|
|
4-8 |
|
|
|
NULL |
osteopathia striata with cranial sclerosis |
AMER1/WTX |
AMER1/WTX |
2-3 |
type 2, 4 |
CLCN7 |
CLCN7 |
5-6 |
|
LRP5 |
LRP5 |
3-4 |
NGS |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN |
4-8 |
NGS |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 |
4-8 |
nonepidermolytic |
KRT16 |
KRT16 |
4-8 |
NGS |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 |
4-8 |
- |
CDKN2A |
CDKN2A |
3-4 |
Pancreatic colipase deficiency |
PNLIP |
PNLIP |
2-4 |
|
PRSS1, SPINK1, CTRC |
PRSS1, SPINK1, CTRC |
2-4 |
PAPA syndrome |
PSTPIP1/CD2BP1 |
PSTPIP1/CD2BP1 |
2-3 |
|
SCN4A |
SCN4A |
3-5 |
|
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 |
2-3 |
17 |
VPS35 |
VPS35 |
4-8 |
23, autosomal recessive, early onset |
VPS13C |
VPS13C |
4-8 |
infantile hypotonic |
SLC18A2 |
SLC18A2 |
4-8 |
juvenile, type 2 |
PRKN |
PRKN |
4-8 |
Parkinson disease |
LRRK2 |
LRRK2 |
4-8 |
Parkinson disease |
diverse |
diverse |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease |
PINK1 |
PINK1 |
4-8 |
Parkinson disease 1, 4 |
SNCA |
SNCA |
4-8 |
|
PNKD |
PNKD |
6-8 |
|
|
|
NULL |
|
|
|
NULL |
mitochondrial |
|
|
3-4 |
Pelizaeus-Merzbacher-like disease |
AIMP1 |
AIMP1 |
5-7 |
Pelizaeus-Merzbacher-like disease |
GJC2 |
GJC2 |
4-5 |
Pelizaeus-Merzbacher-like disease |
HSPD1 |
HSPD1 |
4-5 |
|
PLP1 |
PLP1 |
2-3 |
|
PLP1 |
PLP1 |
2-3 |
|
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
- |
SLC26A4 |
SLC26A4 |
2-4 |
|
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL |
6-8 |
- |
AMHR2 |
AMHR2 |
2-3 |
- |
AMH, AMHR2 |
AMH,AMHR2 |
3-4 |
- |
AMH |
AMH |
2-3 |
- |
CYP1B1 |
CYP1B1 |
2-4 |
- |
PAX6 |
PAX6 |
2-4 |
- |
PITX2 |
PITX2 |
2-4 |
glaucoma 1A |
MYOC |
MYOC |
2-4 |
|
PNMT |
PNMT |
NULL |
|
PAH |
PAH |
|
Schinzel type |
WNT7A |
WNT7A |
4-5 |
|
|
|
NULL |
Pierson syndrome |
LAMB2 |
LAMB2 |
2-4 |
NGS |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 |
4-8 |
type 1 |
POU1F1 |
POU1F1 |
2-4 |
type 1 |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR |
2-4 |
type 3 |
LHX3 |
LHX3 |
2-4 |
type 4 |
LHX4 |
LHX4 |
2-4 |
type 5 |
HESX1 |
HESX1 |
2-4 |
|
RUNX1 |
RUNX1 |
|
autosomal recessive |
PKHD1 |
PKHD1 |
4-6 |
|
|
|
NULL |
- |
ALG8 |
ALG8 |
3-4 |
- |
GANAB |
GANAB |
3-4 |
- |
PRKCSH |
PRKCSH |
3-4 |
- |
SEC63 |
SEC63 |
3-4 |
|
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 |
NULL |
NGS |
APC, MUTYH, NTHL1, POLD1, POLE |
APC, MUTYH, NTHL1, POLD1, POLE |
4-6 |
NGS |
BMPR1A, PTEN, SMAD4, STK11 |
BMPR1A, PTEN, SMAD4, STK11 |
4-6 |
- |
MUTYH |
MUTYH |
4-8 |
- |
MUTYH |
MUTYH |
3-4 |
|
BICC1 |
BICC1 |
NULL |
|
TSEN54 |
TSEN54 |
3-4 |
type 2A, 4, 5 |
TSEN54 |
TSEN54 |
3-4 |
type 1A |
VRK1 |
VRK1 |
3-4 |
|
|
|
NULL |
porencephaly 2 |
COL4A2 |
COL4A2 |
4-8 |
acute hepatic |
ALAD |
ALAD |
4-8 |
|
ALAD, HMBS, PPOX |
ALAD,HMBS,PPOX |
|
|
HMBS |
HMBS |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
NGS |
verschiedene Gene für CPEO |
verschiedene Gene für CPEO |
4-6 |
|
|
|
4-6 |
NGS |
AIP, DICER, MEN1, SDHB |
AIP, DICER, MEN1, SDHB |
4-6 |
protein C receptor deficiency |
PROCR |
PROCR |
3-4 |
protoporphyria, erythropoietic |
FECH |
FECH |
8-20 |
- |
WNK1 |
WNK1 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
WNK4 |
WNK4 |
2-4 |
- |
KLHL3 |
KLHL3 |
2-4 |
purine nucleoside phosphorylse deficienc |
PNP |
PNP |
8-10 |
|
ALDH7A1 |
ALDH7A1 |
2-4 |
pyruvate carboxylase deficiency |
PC |
PC |
2-4 |
pyruvate kinase deficiency |
PKLR |
PKLR |
4-6 |
|
|
|
NULL |
|
FAM20C |
FAM20C |
4-8 |
|
HNF1B/TCF2 |
HNF1B/TCF2 |
2-3 |
|
|
|
|
|
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 |
|
|
|
|
NULL |
NGS |
|
|
4-6 |
renal tubular acidosis, proximal |
SLC4A4 |
SLC4A4 |
2-4 |
|
CCDC66 |
CCDC66 |
2-4 |
|
verschiedene Gene für REDE |
verschiedene Gene für REDE |
4-8 |
- |
RGS9BP |
RGS9BP |
2-4 |
|
TMPRSS3 |
TMPRSS3 |
3-4 |
retinitis pigmentosa |
USH3A |
USH3A |
2-3 |
type 62 |
MAK |
MAK |
3-4 |
- |
RB1 |
RB1 |
4-6 |
- |
RB1 |
RB1 |
4-6 |
NGS |
RB1, MYCN |
RB1, MYCN |
4-8 |
X-linked, juvenile |
RS1 |
RS1 |
2-4 |
|
MECP2 |
MECP2 |
3-4 |
|
MECP2 |
MECP2 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
3-4 |
congenital variant |
FOXG1 |
FOXG1 |
4-5 |
like |
CDKL5 |
CDKL5 |
3-4 |
like |
CDKL5 |
CDKL5 |
2-3 |
like |
NTNG1 |
NTNG1 |
3-4 |
|
|
|
NULL |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
2-3 |
Rubinstein Taybi syndrome |
CREBBP |
CREBBP |
4-8 |
Rubinstein Taybi syndrome |
EP300 |
EP300 |
4-8 |
Rubinstein Taybi syndrome |
CREBBP, EP300 |
CREBBP, EP300 |
4-8 |
|
TWIST1 |
TWIST1 |
2-3 |
Sandhoff disease |
HEXB |
HEXB |
4-8 |
|
SMARCB1 |
SMARCB1 |
2-4 |
SCID and Omenn syndrome |
RAG1 |
RAG1 |
3-4 |
SCID and Omenn syndrome |
RAG2 |
RAG2 |
3-4 |
|
OXCT1 |
OXCT1 |
2-4 |
|
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 |
NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 |
4-8 |
sepiapterin reductase deficiency |
SPR |
SPR |
2-3 |
SESAME sndrome |
KCNJ10 |
KCNJ10 |
3-4 |
|
NR5A1 |
NR5A1 |
2-4 |
- |
AMXY |
AMXY |
3-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
gonadal dysgenesis |
NR0B1 |
NR0B1 |
2-4 |
|
ASXL2 |
ASXL2 |
NULL |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
SHOX deficiency |
SHOX |
SHOX |
2-4 |
Shprintzen-Goldberg syndrome |
SKI |
SKI |
2-6 |
Shwachman-Diamond syndrome |
SBDS |
SBDS |
2-4 |
sialic acid storage disorder |
SLC17A5 |
SLC17A5 |
4-6 |
Simpson-Golabi-Behmel syndrome |
GPC3 |
GPC3 |
2-4 |
|
GPC3, GPC4 |
GPC3,GPC4 |
2-4 |
NGS |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... |
ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, |
4-6 |
|
|
|
|
Charlevoix-Saguenay type |
SACS |
SACS |
14-16 |
type 11 |
SPG11 |
SPG11 |
4-5 |
type 17 |
BSCL2 |
BSCL2 |
4-5 |
type 3 |
ATL1 |
ATL1 |
2-3 |
type 3 |
ATL1 |
ATL1 |
2-4 |
type 31 |
REEP1 |
REEP1 |
3-4 |
type 4 |
SPAST |
SPAST |
2-4 |
type 4 |
SPAST |
SPAST |
2-3 |
type 5 |
CYP7B1 |
CYP7B1 |
3-4 |
type 6 |
NIPA1 |
NIPA1 |
NULL |
type 7 |
SPG7 |
SPG7 |
8-12 |
spermatogenic failure, AZF factor |
USP9Y |
USP9Y |
2-4 |
|
RAD51 |
RAD51 |
2-4 |
type 1 |
IGHMBP2 |
IGHMBP2 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
3-4 |
type 1, 2, 3, 4 |
SMN1 |
SMN1 |
10-14 |
type 3 |
SMN2 |
SMN2 |
2-3 |
X-linked 2 |
UBE1/UBA1 |
UBE1/UBA1 |
5-6 |
|
|
|
4-6 |
|
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
3-4 |
type 1 |
SCA1/ATXN1 |
SCA1/ATXN1 |
4-5 |
type 12 |
SCA12/PPP2R2B |
SCA12/PPP2R2B |
3-4 |
type 17 |
TBP/SCA17 |
TBP/SCA17 |
3-4 |
type 2 |
ATXN2/SCA2 |
ATXN2/SCA2 |
3-4 |
type 3 |
ATXN3/SCA3 |
ATXN3/SCA3 |
3-4 |
type 6 |
CACNA1A/SCA6 |
CACNA1A/SCA6 |
3-4 |
type 7 |
ATXN7/SCA7 |
ATXN7/SCA7 |
3-4 |
type 8 |
SCA8 |
SCA8 |
4-5 |
|
KCND3 |
KCND3 |
|
|
FLNB |
FLNB |
2-3 |
|
FLNB |
FLNB |
3-4 |
|
FLNB |
FLNB |
5-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
4-6 |
congenital type |
COL2A1 |
COL2A1 |
2-3 |
type trada |
TRAPPC2 |
TRAPPC2 |
2-4 |
|
XYLT2 |
XYLT2 |
NULL |
Statin therapy |
SLCO1B1 |
SLCO1B1 |
3-4 |
Statin therapy |
SLCO1B1, ABCG2, ABCB1 |
SLCO1B1, ABCG2, ABCB1 |
3-4 |
NGS |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 |
4-8 |
|
|
|
2-3 |
|
ALDH5A1 |
ALDH5A1 |
NULL |
sucrase-isomaltase deficiency |
SI |
SI |
3-5 |
|
SOD2 |
SOD2 |
4-6 |
surfactant protein deficiency |
ABCA3 |
ABCA3 |
3-4 |
surfactant protein deficiency |
ABCA3, SFTPC |
ABCA3, SFTPC |
2-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
3-4 |
surfactant protein deficiency |
SFTPB |
SFTPB |
2-3 |
surfactant protein deficiency |
SFTPC |
SFTPC |
3-4 |
NGS |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC |
6-8 |
|
|
|
NULL |
|
PIP5K1C |
PIP5K1C |
NULL |
|
MED13 |
MED13 |
|
multiple |
GDF5 |
GDF5 |
3-4 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
systemic-onset juvenile idiopathic arthritis |
IL6 |
IL6 |
1-2 |
|
PF4 |
PF4 |
NULL |
|
HEXA |
HEXA |
2-3 |
|
HEXA |
HEXA |
3-4 |
AB variant |
GM2A |
GM2A |
4-5 |
|
|
|
NULL |
|
SLC19A2 |
SLC19A2 |
2-4 |
thiopurine methyltransferase deficiency |
TPMT |
TPMT |
3 |
- |
ANKRD26 |
ANKRD26 |
4-6 |
- |
GATA1 |
GATA1 |
4-6 |
NGS |
|
|
4-6 |
thrombotic thrombocytopenic purpura |
ADAMTS13 |
ADAMTS13 |
2-4 |
NGS |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 |
DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 |
4-8 |
type 1 |
DYT1 |
DYT1 |
2-3 |
transaldolase deficiency |
TALDO1 |
TALDO1 |
6-8 |
|
|
|
|
Treacher Collins syndrome |
POLR1C |
POLR1C |
3-4 |
Treacher Collins syndrome |
POLR1D |
POLR1D |
3-4 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
6-8 |
Treacher Collins syndrome |
TCOF1 |
TCOF1 |
2-3 |
trichothiodystrophy |
MPLKIP |
MPLKIP |
3-4 |
NGS |
|
|
4-6 |
|
PCGF2 |
PCGF2 |
|
|
TAT |
TAT |
4-6 |
|
UL |
UL |
NULL |
|
ANKS4B |
ANKS4B |
2-4 |
NGS |
divers |
divers |
4-8 |
type 1C |
USH1C |
USH1C |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1F |
PCDH15 |
PCDH15 |
2-4 |
type 1G |
USH1G |
USH1G |
2-4 |
type 1J |
CIB2 |
CIB2 |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2A |
USH2A |
USH2A |
2-4 |
type 2C |
GPR98/ADGRV1 |
GPR98/ADGRV1 |
2-4 |
type 3A |
USH3A |
USH3A |
2-3 |
type 3B |
HARS |
HARS |
2-4 |
type 48 |
CIB2 |
CIB2 |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
ADA2 deficiency |
CECR1/ADA2 |
CECR1/ADA2 |
2-4 |
very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
ACADVL |
2-4 |
type 1A |
CYP27B1 |
CYP27B1 |
3-4 |
Type 1B |
CYP2R1 |
CYP2R1 |
3-4 |
|
VWF |
VWF |
2-4 Wochen |
|
EDNRB, NRTN |
EDNRB, NRTN |
3-4 |
- |
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
SFXN4 |
SFXN4 |
NULL |
|
GHRHR |
GHRHR |
2-4 |
- |
WT1 |
WT1 |
3-4 |
|
verschiedene Gene für WAGR |
verschiedene Gene für WAGR |
NULL |
|
DDX11 |
DDX11 |
3-4 |
- |
EZH2 |
EZH2 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
- |
NSD1 |
NSD1 |
2-4 |
Wiedemann-Steiner syndrome |
KMT2A/MLL1 |
KMT2A/MLL1 |
4-6 |
Williams Beuren syndrome |
CLIP2, ELN, LIMK |
CLIP2, ELN, LIMK |
3-4 |
- |
REST |
REST |
2-4 |
- |
WT1 |
WT1 |
2-4 |
- |
WT1 |
WT1 |
2-4 |
NGS |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wilson disease |
ATP7B |
ATP7B |
2-4 |
Wolman disease |
LIPA |
LIPA |
3-4 |
|
DCAF17 |
DCAF17 |
NULL |
|
WWP2 |
WWP2 |
|
|
|
|
4-6 |
type 1 |
XDH |
XDH |
2-4 |
NGS |
DDB2, ERCC1-5, POLH, XPA, XPC |
DDB2,ERCC1-5, POLH, XPA, XPC |
4-8 |
|
diverse |
diverse |
4-8 |
|
|
|
8-12 |
transient neonatal |
SLC30A2 |
SLC30A2 |
4-6 |
Neurodegeneration with brain iron accumulation |
|
|
|
|
TAOK2 |
TAOK2 |
|
|
GTPBP2 |
GTPBP2 |
2-6 |
Neurodegeneration with brain iron accumulation (NBIA) |
|
|
|
|
KCTD7 |
KCTD7 |
NULL |
|
NAA15 |
NAA15 |
NULL |
|
TBCD |
TBCD |
NULL |
adrenocorticotropic hormone deficiency |
TBX19 |
TBX19 |
2-4 |
|
SLC16A2 |
SLC16A2 |
2-4 |
alpha-methylacetoacetic aciduria |
ACAT1 |
ACAT1 |
2-4 |
|
SLC34A2 |
SLC34A2 |
2-4 |
ANXA1 mutation |
ANXA1 |
ANXA1 |
3-4 |
|
PRKG1 |
PRKG1 |
|
argininemia |
ARG1 |
ARG1 |
2-4 |
aromatase deficiency |
CYP19A1 |
CYP19A1 |
6-8 |
type 3 |
FOXC1 |
FOXC1 |
2-4 |
Best macular dystrophy |
BEST1 |
BEST1 |
3-4 |
|
IHH |
IHH |
2-4 |
|
TNNI3 |
TNNI3 |
2-4 |
dilated |
ACTN2 |
ACTN2 |
NULL |
dilated |
TNNT2 |
TNNT2 |
2-4 |
dilated |
MYH7 |
MYH7 |
2-4 |
dilated or hypertrophic |
NEXN |
NEXN |
2-4 |
hypertrophic |
TPM1 |
TPM1 |
NULL |
hypertrophic |
RBM20 |
RBM20 |
2-4 |
NGS |
ABCC9, ACTC1, ACTN2, ALMS1, ALPK3, ANKRD1, BAG3, BRAF, CALR3, CAV3, CAVIN4, CHRM2, CRYAB, CSRP3, CTNNA3, DES, DMD, DOLK, DSC2, DSG2, DSP, DTNA, EMD, EYA4, FHL1, FKRP, FKTN, FLNC, GAA, GATA4, GATAD1, GLA, HCN4, HFE, HRAS, ILK, JPH2, JUP, KRAS, LAMA4, LAMP2, LDB3, LMNA, LRRC10, MAP2K1, MAP2K2, MIB1, MYB |
ABCC9,ACTC1,ACTN2,ALMS1,ALPK3,ANKRD1,BAG3,BRAF,CALR3,CAV3,CAVIN4,CHRM2,CRYAB,CSRP3,CTNNA3,DES,DMD,DO |
4-6 |
|
|
|
|
CILD5 |
HYDIN |
HYDIN |
3-6 |
NGS |
|
|
4-8 |
|
verschiedene Gene für CFEOM |
verschiedene Gene für CFEOM |
4-8 |
- |
CLCN5 |
CLCN5 |
2-4 |
- |
OCRL/OCRL1 |
OCRL/OCRL1 |
2-4 |
- |
GATA4 |
GATA4 |
2-4 |
- |
GATA6 |
GATA6 |
2-4 |
- |
PTF1A |
PTF1A |
2-4 |
NGS |
ABCC8, EIF2AK3, FOXP3, GATA6, GCK, GLIS3, HNF1B, IER3IP1, INS, KCNJ11, MNX1, NKX2-2, PDX1, PTF1A, WFS1, ZFP57 |
ABCC8,EIF2AK3,FOXP3,GATA6,GCK,GLIS3,HNF1B,IER3IP1,INS,KCNJ11,MNX1,NKX2-2,PDX1,PTF1A,WFS1,ZFP57 |
4-6 |
|
PHIP |
PHIP |
NULL |
|
ROBO3 |
ROBO3 |
2-4 |
|
TBX6 |
TBX6 |
4-8 |
|
DEPDC5 |
DEPDC5 |
5-6 |
Frasier sydrome |
WT1 |
WT1 |
2-4 |
|
CHCHD10 |
CHCHD10 |
2-4 |
galactosemia |
GALT |
GALT |
2-4 |
galactosemia |
GALT, GALE, GALK1 |
GALT, GALE, GALK1 |
4-6 |
galactosemia |
GALT |
GALT |
2-4 |
Generalized epilepsy and paroxysmal dyskinesia |
KCNMA1 |
KCNMA1 |
4-6 |
|
SLC12A3 |
SLC12A3 |
2-4 |
Gitelman syndrome |
SLC12A3 |
SLC12A3 |
2-4 |
GRACILE syndrome |
BCS1L |
BCS1L |
2-4 |
|
HECW2 |
HECW2 |
NULL |
hyper-IgD syndrome |
MVK |
MVK |
3-4 |
hyper-IgD syndrome |
MVK |
MVK |
4-6 |
|
APOB |
APOB |
NULL |
|
APOB |
APOB |
2-4 |
|
LDLR |
LDLR |
3-4 |
- |
APOB |
APOB |
2-3 |
- |
CETP |
CETP |
2-4 |
- |
LDLR |
LDLR |
2-4 |
|
SLC34A3 |
SLC34A3 |
2-4 |
|
SLC34A1 |
SLC34A1 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
NGS |
ABCA12, ALOX12B, ALOXE3, CYP4F22, KRT1, KRT10, LIPN, NIPAL4, STS, TGM1 und weitere |
ABCA12, ALOX12B, ALOXE3, CYP4F22, KRT1, KRT10, LIPN, NIPAL4, STS, TGM1 und weitere |
4-8 |
ichthyosis, congenital, autosomal recessive 1 |
TGM1 |
TGM1 |
4-6 |
|
ROGDI |
ROGDI |
|
type 1 |
GUCY2D |
GUCY2D |
4-5 |
type 10 |
CEP290 |
CEP290 |
3-5 |
type 11 |
IMPDH1 |
IMPDH1 |
3-4 |
type 12 |
RD3 |
RD3 |
3-4 |
type 13 |
RDH12 |
RDH12 |
3-4 |
type 14 |
LRAT |
LRAT |
3-4 |
type 15 |
TULP1 |
TULP1 |
3-4 |
type 16 |
KCNJ13 |
KCNJ13 |
3-4 |
type 2 |
RPE65 |
RPE65 |
3-4 |
type 3 |
SPATA7 |
SPATA7 |
3-4 |
type 4 |
AIPL1 |
AIPL1 |
4-6 |
type 5 |
LCA5 |
LCA5 |
3-4 |
type 6 |
RPGRIP1 |
RPGRIP1 |
3-4 |
type 6 |
RPGRIP1 |
RPGRIP1 |
3-4 |
type 7 |
CRX |
CRX |
3-4 |
type 7 |
GUCY2D; RDH12; RPGRIP1; CEP290 (nur Intron 26) |
GUCY2D; RDH12; RPGRIP1; CEP290 (nur Intron 26) |
3-4 |
type 8 |
AIPL1, CRB1, CRX, LCA5, RPE65 |
AIPL1, CRB1, CRX, LCA5, RPE65 |
2-4 |
type 8 |
CRB1 |
CRB1 |
4-5 |
type 9 |
NMNAT1 |
NMNAT1 |
3-4 |
metachromatic |
PSAP |
PSAP |
6-10 |
leukoencaphalopathy |
|
|
4-8 |
NGS |
ABCA3, CSF2RA, CSF2RB, MARS, SFTPB, NKX2-1 etc |
ABCA3, CSF2RA, CSF2RB, MARS, SFTPB, NKX2-1 etc |
6-10 |
|
PLCB1 |
PLCB1 |
NULL |
|
RAB18 |
RAB18 |
NULL |
MEN2A |
RET |
RET |
3-4 |
|
SSR4 |
SSR4 |
NULL |
|
TOE1 |
TOE1 |
NULL |
|
|
|
4-8 |
PLA2G6-associated neurodegeneration (PLAN) |
PLA2G6 |
PLA2G6 |
3-4 |
progressive external |
POLG1 |
POLG1 |
4-8 |
progressive external |
POLG1 |
POLG1 |
2-4 |
type 1, 2, 3, 4 |
COL1A1 |
COL1A1 |
4-6 |
type 2, 3, 4 |
COL1A2 |
COL1A2 |
4-6 |
type 2, 3, 4 |
COL1A2 |
COL1A2 |
4-6 |
type 5 and type 6 |
IFITM5 |
IFITM5 |
1-3 |
|
FLNA |
FLNA |
NULL |
P450 oxidoreductase deficiency |
POR |
POR |
2-4 |
2 |
TGM5 |
TGM5 |
5-7 |
NGS |
FH, GDNF, KIF1B, MAX, NF1, RET, SDHA, SDHB, SDHC, SDHD, TMEM127, VHL, MEN1, TSC1, TSC2 |
FH, GDNF, KIF1B, MAX, NF1, RET, SDHA, SDHB, SDHC, SDHD, TMEM127, VHL, MEN1, TSC1, TSC2 |
4-8 |
|
SDHB, SDHC, SDHD, SDHAF1, SDHAF2 |
SDHB, SDHC, SDHD, SDHAF1,SDHAF2 |
2-3 |
- |
SMAD4 |
SMAD4 |
4-8 |
- |
SMAD4 |
SMAD4 |
4-8 |
porphyria cutanea tarda |
FECH, UROS, UROD and CPOX |
FECH, UROS, UROD and CPOX |
2-4 |
porphyria cutanea tarda |
UROS |
UROS |
8-20 |
|
CSTB |
CSTB |
3-4 |
Progressive Myoclonic Epilepsy |
CSTB |
CSTB |
4-5 |
|
AIP |
AIP |
3-4 |
pyruvate dehydrogenase E3 deficiency |
DLD |
DLD |
2-4 |
Refsum syndrome |
diverse Gene |
diverse Gene |
4-8 |
NGS |
ADAMTS10, ADAMTS17, ADAMTSL2, BMPR1B, COL11A1, COL11A2, DVL1, DVL3, EXT1, FBN1, FGFR2, FGFR3, FLNA, FZD2, GDF5, GPC6, GSC, IFT122, IFT140, IFT43, IHH, LIFR, LRP4, LTBP2, LTBP3, MAB21L2, MIR140, NPR2, NXN, PDE4D, PRKAR1A, ROR2, SHOX, SLC26A2, SLCO5A1, ..... |
ADAMTS10, ADAMTS17, ADAMTSL2, BMPR1B, COL11A1, COL11A2, DVL1, DVL3, EXT1, FBN1, FGFR2, FGFR3, FLNA, |
4-6 |
|
|
|
NULL |
split-hand/foot malformation |
WNT10B |
WNT10B |
2-4 |
|
ABCA4, IMPG1, ELOVL4, PROM1 |
ABCA4, IMPG1, ELOVL4, PROM1 |
4-6 |
|
|
|
NULL |
|
SALL1 |
SALL1 |
3-4 |
type1 |
WFS1 |
WFS1 |
2-4 |
X-linked hyper-IgM syndrome |
CD40LG, CD40, UNG, AICDA |
CD40LG, CD40, UNG, AICDA |
5-6 Wochen |
neurodegeneration with brain iron accumulation1 |
PLA2G6 + PANK2 |
PLA2G6 + PANK2 |
2-3 |
neurodegenerative disease1 |
|
|
|
Aicardi-Goutieres syndrome |
TREX1 |
TREX1 |
2-4 |
NGS |
IFIH1, RNASEH2A, RNASEH2B, RNASEH2C, TREX1, SAMHD1, ADAR |
IFIH1, RNASEH2A, RNASEH2B, RNASEH2C, TREX1, SAMHD1, ADAR |
4-8 |
- |
|
|
4-8 Wochen |
angioedema |
C1NH/SERPING1 |
C1NH/SERPING1 |
3-4 |
|
ATN1 |
ATN1 |
2-3 |
dihydropyrimidin dehydrogenase deficiency |
DPYD |
DPYD |
1 |
|
COL9A2 |
COL9A2 |
|
|
|
|
4-8 |
|
GRIN1 |
GRIN1 |
NULL |
Huntington disease-like 2 |
JPH3 |
JPH3 |
3-4 |
|
CASR |
CASR |
2-4 |
type 1 |
CASR |
CASR |
2-4 |
type 2 |
GNA11 |
GNA11 |
2-4 |
type 3 |
AP2S1 |
AP2S1 |
2-4 |
IMAGe syndrome |
CDKN1C |
CDKN1C |
2-4 |
IRIDA syndrome |
TMPRSS6 |
TMPRSS6 |
2-4 |
type 4 |
CAVIN1/PTRF |
CAVIN1/PTRF |
2-4 |
|
ATRX |
ATRX |
NULL |
|
HIBCH |
HIBCH |
2-4 |
|
DOK7 |
DOK7 |
NULL |
neurodegenerative disease |
PANK2, PLA2G6, C19ORF12, FA2H, ATP13A2, WDR45, COASY, FTL, CP, DCAF17, RAB39B |
PANK2,PLA2G6,C19ORF12,FA2H,ATP13A2,WDR45,COASY,FTL,CP,DCAF17,RAB39B |
4-8 |
|
GNAO1 |
GNAO1 |
|
|
SCN10A |
SCN10A |
4-6 |
|
SCN11A |
SCN11A |
4-6 |
|
SCN9A |
SCN9A |
2-4 |
type 1a |
SPTLC1 |
SPTLC1 |
NULL |
Type 2 |
|
|
4-8 |
Type 2 |
KIF1A |
KIF1A |
NULL |
Type 2 |
WNK1 |
WNK1 |
4-5 |
Type 4 |
NTRK1 |
NTRK1 |
4-6 |
Type 5 |
NGF |
NGF |
3-4 |
type IC |
SPTLC2 |
SPTLC2 |
NULL |
NGS |
ACVRL1, ENG, SMAD4, GDF2 |
ACVRL1, ENG, SMAD4, GDF2 |
4-6 |
type 1 |
ENG |
ENG |
4-6 |
type 1,2 |
ENG, ACVRL1 |
ENG, ACVRL1 |
2-3 |
type 2 |
ACVRL1 |
ACVRL1 |
4-6 |
type 5 |
GDF2 |
GDF2 |
4-6 |
Papillon-Lefèvre syndrome |
CTSC |
CTSC |
4-5 |
|
ADCY5, PRRT2, SLC2A1, SCN8A, KCNMA1, PNKD |
ADCY5, PRRT2, SLC2A1, SCN8A, KCNMA1, PNKD |
4-8 |
|
POLD1 |
POLD1 |
|
type 1a |
GNAS |
GNAS |
2-4 |
type 1a |
GNAS |
GNAS |
4-6 |
NGS |
ALPL, ANO5, ATP6V0A2, B3GALT6, B4GALT7, BMP1, COL1A1, COL1A2, CREB3L1, CRTAP, DDX58, FKBP10, GORAB, IFIH1, IFITM5, LRP5, MBTPS2, NBAS, NOTCH2, P3H1, P4HB, PLOD2, PLS3, POLR3A, PPIB, PYCR1, SEC24D, SERPINF1, SERPINH1, SGMS2, SP7, SPARC, TENT5A, ........ |
ALPL, ANO5, ATP6V0A2, B3GALT6, B4GALT7, BMP1, COL1A1, COL1A2, CREB3L1, CRTAP, DDX58, FKBP10, GORAB, |
4-6 |
NGS |
APC, CDKN1B, DICER1, FOXE1, HABP2, MEN1, NKX2-1, PRKAR1A, RET, PTEN, TP53 |
APC, CDKN1B, DICER1, FOXE1, HABP2, MEN1, NKX2-1, PRKAR1A, RET, PTEN, TP53 |
4-8 |
triple A syndrome |
AAAS |
AAAS |
2-4 |
type 1 |
TSC1 |
TSC1 |
3-4 |
type 2 |
TSC2 |
TSC2 |
4-5 |
|
|
|
2-3 |
|
verschiedene Gene für WAS |
verschiedene Gene für WAS |
4-6 |
|
|
|
NULL |
neurofibromatosis |
|
|
|
|
WDR91 |
WDR91 |
NULL |
17-beta hydrosysteroid dehydrogenase 3 deficiency |
HSD17B3 |
HSD17B3 |
2-4 |
- |
GP1BA |
GP1BA |
2-4 |
NGS |
RCA2 (FANCD1), BRIP1 (FANCJ), FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, PALB2, MPL, SBDS... |
RCA2 (FANCD1), BRIP1 (FANCJ), FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, |
4-8 |
|
|
|
NULL |
|
RPS6KA3 |
RPS6KA3 |
NULL |
Danon disease |
LAMP2 |
LAMP2 |
2-4 |
|
|
|
NULL |
|
EGFR |
EGFR |
NULL |
|
CHD2 |
CHD2 |
NULL |
- |
LTBP2 |
LTBP2 |
3-4 |
|
PTCH1 |
PTCH1 |
|
- |
LDLRAP1 |
LDLRAP1 |
2-4 |
- |
PCSK9 |
PCSK9 |
2-4 |
- |
STAP1 |
STAP1 |
2-4 |
|
PGAP3 |
PGAP3 |
NULL |
NGS |
|
|
4-8 |
qualitative |
BCR-ABL |
BCR-ABL |
1-2 |
|
SGCA, SGCB, SGCD, SGCG und FKRP |
SGCA, SGCB, SGCD, SGCG und FKRP |
|
MYH9-related disorders |
MYH9 |
MYH9 |
2-4 |
|
|
|
NULL |
NGS |
NF1, NF2, SMARCB1, SPRED1 |
NF1, NF2, SMARCB1, SPRED1 |
4-6 |
type 1 |
NF1 |
NF1 |
4-6 |
type 1 |
NF1 |
NF1 |
2-3 |
type 2 |
NF2 |
NF2 |
4-6 |
type 2 |
NF2 |
NF2 |
2-4 |
type 3 |
SMARCB1 |
SMARCB1 |
4-6 |
|
|
|
4-8 |
paroxysmal nocturnal hemoglobinuria |
PIGA |
PIGA |
2-4 |
paroxysmal nocturnal hemoglobinuria |
PIGA, PIGT |
PIGA,PIGT |
2-4 |
|
CLPP; HARS2, HSD27B4, LARS2 |
CLPP; HARS2, HSD27B4, LARS2 |
4-8 |
autosomale recessive |
HARS2 |
HARS2 |
2-4 |
autosomale recessive |
HSD17B4 |
HSD17B4 |
3-4 |
type 3 |
CLPP |
CLPP |
3-4 |
type 4 |
LARS2 |
LARS2 |
3-4 |
|
CHD1 |
CHD1 |
NULL |
- |
DNAJB11 |
DNAJB11 |
3-4 |
autosomal dominant |
GANAB |
GANAB |
2-4 |
autosomal dominant |
PKD1 |
PKD1 |
2-4 |
autosomal dominant |
PKD1 |
PKD1 |
2 |
autosomal dominant |
PKD2 |
PKD2 |
2-4 |
propionic acidemia |
PCCA |
PCCA |
6-10 |
propionic acidemia |
PCCA, PCCB |
PCCA, PCCB |
6-10 |
propionic acidemia |
PCCA, PCCB |
PCCA, PCCB |
NULL |
propionic acidemia |
PCCB |
PCCB |
6-10 |
renal |
NR3C2 |
NR3C2 |
2-4 |
- |
HNF1B/TCF2 |
HNF1B/TCF2 |
2-4 |
|
diverse Gene |
diverse Gene |
4-6 |
|
SRD5A3 |
SRD5A3 |
NULL |
NGS |
verschiedene Gene für STICK |
verschiedene Gene für STICK |
4-8 |
type 1 |
COL2A1 |
COL2A1 |
4-6 |
type 1 |
COL2A1 |
COL2A1 |
4-6 |
type 1 |
COL2A1 |
COL2A1 |
2-3 |
type 2 |
COL11A1 |
COL11A1 |
4-6 |
type 2 |
COL11A1 |
COL11A1 |
2-4 |
autoimmune lymphoproliferative type 2 |
CASP10 |
CASP10 |
2-4 |
|
AIRE, CASP10, CASP8, FADD, FAS, FASLG, FOXP3, IL2RA, ITCH, PRKCD, STAT3, TNS3 |
AIRE, CASP10, CASP8, FADD, FAS, FASLG, FOXP3, IL2RA, ITCH, PRKCD, STAT3, TNS3 |
4-6 |
|
RBM10 |
RBM10 |
3-4 |
MLPA analysis UPD(14)mat |
|
|
2-4 |
von Willebrand diseased |
VWF |
VWF |
4-6 |
von Willebrand diseased |
VWF |
VWF |
2-4 |
Type I |
PAX3, MITF, SOX10 |
PAX3, MITF, SOX10 |
7-8 |
Type I |
PAX3 |
PAX3 |
3-4 |
Type II |
SOX10 |
SOX10 |
3-4 |
Type II |
MITF |
MITF |
3-4 |
Type II |
SNAI2 |
SNAI2 |
3-4 |
Type II |
SNAI2 |
SNAI2 |
3-4 |
Type III |
PAX3 |
PAX3 |
3-4 |
Type IV |
SOX10 |
SOX10 |
3-4 |
neuromyotonia and axonal neuropathy* |
|
|
|
|
CDK13 |
CDK13 |
NULL |
|
CHGA |
CHGA |
NULL |
|
CTBP1 |
CTBP1 |
NULL |
|
FOXA2 |
FOXA2 |
NULL |
|
MACF1 |
MACF1 |
NULL |
|
PCDH12 |
PCDH12 |
NULL |
|
PCM1 |
PCM1 |
|
|
|
|
|
|
PTCHD1 |
PTCHD1 |
NULL |
|
RREB1 |
RREB1 |
NULL |
|
SHANK2 |
SHANK2 |
NULL |
|
TANC2 |
TANC2 |
2-4 |
|
TRIP12 |
TRIP12 |
NULL |
|
|
|
NULL |
|
HMGCL |
HMGCL |
4-6 |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
MCCC1 |
2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency |
MCCC1, MCCC2 |
MCCC1, MCCC2 |
4-8 |
type 1 |
AUH |
AUH |
2-4 |
3M syndrome |
CCDC8 |
CCDC8 |
2-4 |
3M syndrome |
CUL7 |
CUL7 |
2-4 |
3M syndrome |
OBSL1 |
OBSL1 |
2-4 |
3MC syndrome |
MASP1 |
MASP1 |
5-6 |
abetalipoproteinemia |
MTP |
MTP |
4-6 |
NGS |
CNGA3, CNGB3, GNAT2, PDE6C, ATF6 |
CNGA3,CNGB3,GNAT2,PDE6C,ATF6 |
4-6 |
type 2 |
CNGA3 |
CNGA3 |
3-4 |
type 3 |
CNGB3 |
CNGB3 |
3-4 |
type 4 |
GNAT2 |
GNAT2 |
3-4 |
- |
GLI3 |
GLI3 |
3-5 |
- |
GLI3 |
GLI3 |
2-3 |
|
GLI3, KIF7 |
GLI3, KIF7 |
NULL |
acrodermatitis enteropathica |
SLC39A4 |
SLC39A4 |
3-4 |
|
DLL4 |
DLL4 |
2-4 |
|
DOCK6 |
DOCK6 |
2-4 |
|
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ |
4-8 |
|
ERIS |
ERIS |
4-5 |
type 7 |
TMC1 |
TMC1 |
4-5 |
X-linked |
ABCD1 |
ABCD1 |
2-4 |
ADTKD |
|
|
NULL |
|
GNAS |
GNAS |
2-4 |
Alexander syndrome |
GFAP |
GFAP |
4-6 |
alkaptonuria |
HGD |
HGD |
2-4 |
Alpha-ketoglutarate dehydrogenase deficiency |
OGDH |
OGDH |
3-5 |
|
|
|
4-6 |
|
IGFALS |
IGFALS |
2-4 |
Alzheimer disease |
APP, PSEN1, PSEN2, apoE4 |
APP, PSEN1, PSEN2, apoE4 |
4-8 |
Alzheimer disease |
APP |
APP |
4-8 |
Alzheimer disease |
PSEN1 |
PSEN1 |
4-8 |
|
TARDBP |
TARDBP |
3-4 |
|
SEPTIN9 |
SEPTIN9 |
|
Anderman syndrome |
SLC12A6 |
SLC12A6 |
NULL |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
androgen insensitivity syndrome |
AR |
AR |
2-4 |
hemolytic |
CD59 |
CD59 |
2-4 |
- |
SEC23B |
SEC23B |
2-4 |
NGS |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B |
4-6 |
type 1 |
CDAN1 |
CDAN1 |
2-4 |
|
PAX6, WT1, SOX2 |
PAX6, WT1, SOX2 |
2-4 |
|
ANK3 |
ANK3 |
|
anticoagulant sensitivity |
CYP4F2 |
CYP4F2 |
2-3 |
anticoagulant sensitivity |
VKORC1 |
VKORC1 |
2-3 |
antithrombin 3 deficiency |
SERPINC1 |
SERPINC1 |
4-6 |
NGS |
|
|
4-6 |
Apert syndrome |
FGFR2 |
FGFR2 |
2-3 |
- |
FOXD3 |
FOXD3 |
2-4 |
- |
FOXE3 |
FOXE3 |
2-4 |
apparent mineralocorticoid excess |
HSD11B2 |
HSD11B2 |
2-4 |
argininosuccinic aciduria |
ASL |
ASL |
2-4 |
|
DZIP1L |
DZIP1L |
NULL |
|
PKHD1L1 |
PKHD1L1 |
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
|
|
|
4-6 |
Ashkenazi Jewish panel |
|
|
7-8 |
Ashkenazi Jewish panel |
|
|
7-8 |
oculomotor apraxia type 1 |
APTX |
APTX |
6-8 |
ataxia with vitamin E deficiency |
TTPA |
TTPA |
5-6 |
|
HARS2 |
HARS2 |
2-4 |
autosomal dominant, type 1 |
DIAPH3 |
DIAPH3 |
4-5 |
autosomal-recessive, type 59 |
DFNB59 |
DFNB59 |
2-4 |
|
NLGN1 |
NLGN1 |
|
|
PTPN4 |
PTPN4 |
|
type 1 |
FAS |
FAS |
2-4 |
type 1 |
FASLG/FASL |
FASLG/FASL |
2-4 |
type 2B |
CASP8 |
CASP8 |
2-4 |
type 3 |
PRKCD |
PRKCD |
2-4 |
type 1 |
ACTB |
ACTB |
2-4 |
type 2 |
ACTG1 |
ACTG1 |
2-4 |
Methylation analysis H19-DMR and KvDMR1 |
H19, KCNQ1OT1 |
H19,KCNQ1OT1 |
2-4 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
4-6 |
sequence analysis CDKN1C |
CDKN1C |
CDKN1C |
2-4 |
sequence analysis NLRP2 |
NLRP2 |
NLRP2 |
2-4 |
|
KCNQ3 |
KCNQ3 |
NULL |
- |
GP1BB |
GP1BB |
4-6 |
beta-propeller protein-associated neurodegeneratio |
WDR45 |
WDR45 |
2-4 |
Bietti crystalline corneoretinal dystrophy |
CYP4V2 |
CYP4V2 |
4-6 |
|
|
|
NULL |
|
SLC19A3 |
SLC19A3 |
2-4 |
|
BTD |
BTD |
NULL |
|
FLCN |
FLCN |
|
- |
DICER1 |
DICER1 |
4-8 |
- |
DICER1 |
DICER1 |
4-8 |
autosomal dominant |
FOXL2 |
FOXL2 |
2-4 |
Bloom syndrome |
BLM |
BLM |
3-4 |
Bloom syndrome |
|
|
8-10 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
OPN1MW |
OPN1MW |
3-4 |
|
|
|
2-3 |
type 1 |
FKBP10 |
FKBP10 |
2-4 |
type 2 |
PLOD2 |
PLOD2 |
2-4 |
Brunner syndrome |
MAOA |
MAOA |
6-8 |
|
TXNL4A |
TXNL4A |
2-4 |
butyrylcholinesterase deficiency |
BCHE |
BCHE |
4-5 |
Börjeson-Forssman-Lehmann syndrome |
PHF6 |
PHF6 |
2-4 |
CACH syndrome |
EIF2B1 |
EIF2B1 |
3-4 |
CACH syndrome |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 |
6-8 |
CACH syndrome |
EIF2B2 |
EIF2B2 |
4-5 |
CACH syndrome |
EIF2B3 |
EIF2B3 |
4-5 |
CACH syndrome |
EIF2B4 |
EIF2B4 |
4-5 |
CACH syndrome |
EIF2B5 |
EIF2B5 |
4-5 |
Caffey disease |
COL1A1 |
COL1A1 |
4-6 |
Caffey disease |
COL1A1 |
COL1A1 |
2-3 |
|
|
|
4-8 |
NGS |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF |
2 |
carbamoylphosphate synthetase 1 deficiency |
CPS1 |
CPS1 |
2-4 |
- |
MYBPC3 |
MYBPC3 |
2-4 |
NGS |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere |
4-6 |
NGS |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 |
4-6 |
type 1 |
PRKAR1A |
PRKAR1A |
4-6 |
- |
SLC22A5 |
SLC22A5 |
2-4 |
type 2 |
CPT2 |
CPT2 |
2-4 |
type 1A |
CPT1A |
CPT1A |
2-4 |
|
LC25A20 |
LC25A20 |
2-4 |
cartilage-hair hypoplasia |
RMRP |
RMRP |
2-3 |
|
DSP |
DSP |
2-4 |
type 6 |
EPHA2 |
EPHA2 |
2-4 |
|
NHS |
NHS |
2-4 |
type 17 |
CRYBB1 |
CRYBB1 |
2-4 |
type 2 |
CRYGC |
CRYGC |
2-4 |
type 3 |
CRYBB2 |
CRYBB2 |
2-4 |
type 31 |
CHMP4B |
CHMP4B |
2-4 |
type 4 |
CRYGD |
CRYGD |
2-4 |
type 9 |
CRYAA |
CRYAA |
2-4 |
Catechol-O methyltransferase activity |
COMT |
COMT |
2-3 |
|
CDH10 |
CDH10 |
|
cerebral cavernous malformations |
KRIT1, CCM2, PDCD10 |
KRIT1, CCM2, PDCD10 |
4-8 |
Chanarin-Dorfman syndrome |
ABHD5 |
ABHD5 |
4-8 |
dominant intermediate B |
DNM2 |
DNM2 |
3-4 |
dominant intermediate D |
MPZ |
MPZ |
4-5 |
type 1A |
PMP22 |
PMP22 |
2-3 |
type 1B |
MPZ |
MPZ |
3-4 |
type 1C |
LITAF |
LITAF |
3-4 |
type 1D |
EGR2 |
EGR2 |
3-4 |
type 1E |
PMP22 |
PMP22 |
3-4 |
type 2A |
MFN2 |
MFN2 |
3-4 |
type 2F |
HSPB1 |
HSPB1 |
3-4 |
type 2H |
GDAP1 |
GDAP1 |
3-4 |
type 2I |
MPZ |
MPZ |
3-4 |
type 2J |
MPZ |
MPZ |
4-5 |
type 2K |
GDAP1 |
GDAP1 |
3-4 |
type 2N |
AARS |
AARS |
NULL |
type 2O |
DYNC1H1 |
DYNC1H1 |
2-4 |
type 2U |
MARS |
MARS |
NULL |
type 4A |
GDAP1 |
GDAP1 |
3-4 |
type 4B1 |
|
|
4-8 |
type 4C |
SH3TC2 |
SH3TC2 |
3-4 |
type 4E |
EGR2 |
EGR2 |
3-4 |
type 4F |
PRX |
PRX |
3-4 |
type 4J |
FIG4 |
FIG4 |
2-4 |
type 5 |
PRPS1 |
PRPS1 |
3-4 |
X-chromsomal |
Cx32 / GJB1 |
Cx32 / GJB1 |
3-4 |
|
LRSAM1 |
LRSAM1 |
|
|
SBF2 |
SBF2 |
NULL |
|
NEFL |
NEFL |
2-4 |
|
CHD7 |
CHD7 |
2-4 |
Chediak-Higashi syndrome |
LYST |
LYST |
4-6 |
cherubism |
SH3BP2 |
SH3BP2 |
4-6 |
|
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... |
8-12 |
Blomstrand type |
PTH1R |
PTH1R |
NULL |
metaphyseal, Schmid type |
COL10A1 |
COL10A1 |
2-3 |
Chorea Huntington |
HTT |
HTT |
4-5 |
|
|
|
NULL |
|
|
|
NULL |
chronic granulomatosis |
CYBB |
CYBB |
4-6 |
chronic granulomatosis |
CYBA, CYBB, NCF1, NCF2, NCF4 |
CYBA, CYBB, NCF1, NCF2, NCF4 |
10-12 |
|
IgVH |
IgVH |
2-3 |
NGS |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 |
4-6 |
CINCA syndrome |
CIAS1 / NLRP3 |
CIAS1 / NLRP3 |
3-4 |
NGS |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
ALX4, FIG4, MSX2, RUNX2, VAC14 |
4-6 |
|
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 |
CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
4-6 |
|
VPS13B/COH1 |
VPS13B/COH1 |
2-3 |
coloboma |
PAX6 |
PAX6 |
3-4 |
|
MSH6, EPCAM |
MSH6, EPCAM |
4-6 |
NGS |
MLH1, MSH2, MSH6, PMS2, EPCAM |
MLH1, MSH2, MSH6, PMS2, EPCAM |
4-8 |
type 1 / 2 |
MLH1, MSH2 |
MLH1, MSH2 |
4-6 |
type 2 |
MLH1 |
MLH1 |
4-6 |
type 4 |
PMS2 |
PMS2 |
4-6 |
type 5 |
MSH6 |
MSH6 |
4-6 |
type 7 |
MLH3 |
MLH3 |
4-6 |
type 8 |
EPCAM |
EPCAM |
4-8 |
type 8 |
EPCAM |
EPCAM |
3-4 |
type1 |
MSH2 |
MSH2 |
4-6 |
|
C1QTNF5 |
C1QTNF5 |
3-4 |
- |
OPN1LW |
OPN1LW |
3-4 |
- |
AIPL1 |
AIPL1 |
2-4 |
- |
C21ORF2 |
C21ORF2 |
3-4 |
- |
CDH3 |
CDH3 |
3-4 |
- |
CRX |
CRX |
3-4 |
- |
CTNNA1 |
CTNNA1 |
3-4 |
- |
FBLN5 |
FBLN5 |
NULL |
- |
GUCY2D |
GUCY2D |
3-4 |
- |
HMCN1 |
HMCN1 |
4-8 |
- |
KCNV2 |
KCNV2 |
3-4 |
- |
PDE6C |
PDE6C |
3-4 |
- |
PRPH2, BEST1 |
PRPH2, BEST1 |
3-4 |
- |
RAX2 |
RAX2 |
3-4 |
- |
PRPH2 |
PRPH2 |
3-4 |
- |
RGS9 |
RGS9 |
3-4 |
- |
RIMS1 |
RIMS1 |
3-4 |
- |
RPGR |
RPGR |
3-4 |
- |
RPGRIP1 |
RPGRIP1 |
3-4 |
Type 20 |
POC1B |
POC1B |
2-4 |
Type 21 |
DRAM2 |
DRAM2 |
2-4 |
type 3 |
CACNA1F |
CACNA1F |
4-5 |
type 3 |
ABCA4 |
ABCA4 |
2-4 |
type 3 |
GUCA1A |
GUCA1A |
3-4 |
type 3 |
SEMA4A |
SEMA4A |
NULL |
X-linked |
ORF15, RPGR |
ORF15, RPGR |
4-8 |
Jalili syndrome |
CNNM4 |
CNNM4 |
2-4 |
coproporphyria |
CPOX |
CPOX |
8-20 |
|
DCN |
DCN |
2-4 |
corneal dystrophy |
SLC4A11 |
SLC4A11 |
2-4 |
corneal dystrophy |
ZEB1 |
ZEB1 |
2-4 |
|
RAD21 |
RAD21 |
NULL |
|
|
|
4-6 |
|
SMC3 |
SMC3 |
NULL |
|
HRAS |
HRAS |
2-4 |
NGS |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD |
4-6 |
type 1 |
PTEN |
PTEN |
3-4 |
type 1 |
PTEN |
PTEN |
2-3 |
type 1 |
PTEN |
PTEN |
2-3 |
type 2 |
SDHB |
SDHB |
3-4 |
type 3 |
SDHD |
SDHD |
3-4 |
type 4 |
KLLN |
KLLN |
3-4 |
type 5 |
PIK3CA |
PIK3CA |
3-4 |
type 6 |
AKT1 |
AKT1 |
3-4 |
type 7 |
SEC23B |
SEC23B |
3-4 |
NGS |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... |
ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 |
4-6 |
Crouzon syndrome with acanthosis nigricans |
FGFR3 |
FGFR3 |
3-4 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
|
ALG9 |
ALG9 |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
cystinosis |
CTNS |
CTNS |
2-4 |
|
|
|
NULL |
|
|
|
NULL |
Darier disease |
ATP2A2 |
ATP2A2 |
4-6 |
NGS |
|
|
4-6 |
|
DSPP |
DSPP |
NULL |
|
WAC |
WAC |
NULL |
Desbuquois Syndrome |
CANT1 |
CANT1 |
3-4 |
- |
AQP2 |
AQP2 |
2-4 |
- |
AVPR2 |
AVPR2 |
2-4 |
- |
ABCC8 |
ABCC8 |
2-4 |
- |
EIF2AK3 |
EIF2AK3 |
2-4 |
- |
GCK |
GCK |
2-4 |
- |
INS |
INS |
2-4 |
- |
INS |
INS |
2-4 |
- |
KCNJ11 |
KCNJ11 |
2-4 |
- |
ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR |
ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR |
2-4 |
Diamond Blackfan anemia |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 |
4-6 |
Diamond Blackfan anemia |
RPS19 |
RPS19 |
2-4 |
DiGeorge syndrome |
TBX1 |
TBX1 |
4-5 |
isolated congenital |
HPGD |
HPGD |
2-4 |
|
FLNC |
FLNC |
NULL |
|
|
|
4-8 |
Donnai-Barrow syndrome |
LRP2 |
LRP2 |
4-6 |
Doyne honeycomb degeneration of retina |
EFEMP1 |
EFEMP1 |
3-4 |
Dubin Johnson syndrome |
ABCC2 |
ABCC2 |
4-6 |
|
DYM |
DYM |
2-4 |
spondylocostal |
DLL3 |
DLL3 |
4-6 |
spondylocostal |
HES7 |
HES7 |
4-6 |
spondylocostal |
LFNG |
LFNG |
4-6 |
spondylocostal |
MESP2 |
MESP2 |
4-6 |
postaxial |
DHODH |
DHODH |
2-4 |
acromesomelic , Maroteaux Type |
NPR2 |
NPR2 |
4-6 |
acromesomelic, Hunter-Thompson type |
GDF5 |
GDF5 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-4 |
campomelic |
SOX9 |
SOX9 |
2-3 |
cleidocrania |
RUNX2 |
RUNX2 |
2-3 |
cleidocranial |
RUNX2 |
RUNX2 |
2-4 |
dyssegmental, Silverman-Handmaker type |
HSPG2 |
HSPG2 |
4-6 |
familial isolated arrhythmogenic ventricular |
DSG2 |
DSG2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
familial isolated arrhythmogenic ventricular |
PKP2 |
PKP2 |
2-4 |
frontometaphyseal |
MAP3K7 |
MAP3K7 |
4-6 |
multiple epiphyseal, type 4 |
SLC26A2 |
SLC26A2 |
2-4 |
oculodentodigital |
GJA1 |
GJA1 |
3-4 |
odontoonychoderma |
WNT10A |
WNT10A |
NULL |
thanatophoric |
FGFR3 |
FGFR3 |
3-4 |
- |
HESX1 |
HESX1 |
8-9 |
|
DSC2 |
DSC2 |
NULL |
DYT25 |
GNAL |
GNAL |
5-6 |
|
VLDLR |
VLDLR |
NULL |
Eagle-Barret syndrome |
CHRM3 |
CHRM3 |
5-6 |
hair/nail type |
KRT85 |
KRT85 |
4-8 |
|
EGFR |
EGFR |
4-6 |
|
COL5A1 |
COL5A1 |
NULL |
- |
EVC |
EVC |
2-4 |
- |
EVC, EVC2 |
EVC, EVC2 |
2-4 |
- |
EVC2 |
EVC2 |
2-4 |
breast cancer |
|
|
1 |
congenital, due to enteropeptidase deficiency |
TMPRSS15/PRSS7 |
TMPRSS15/PRSS7 |
2-4 |
|
SLF2 |
SLF2 |
2-4 |
|
ACY1 |
ACY1 |
|
|
SCN8A |
SCN8A |
4-5 |
|
SYNJ1 |
SYNJ1 |
NULL |
- |
COL7A1, KRT5 |
COL7A1, KRT5 |
2-3 |
- |
COL17A1 |
COL17A1 |
6-8 |
dystrophica |
COL7A1 |
COL7A1 |
6-8 |
Herlitz type |
LAMC2 |
LAMC2 |
3-4 |
junctional |
LAMA3 |
LAMA3 |
4-5 |
junctional, Herlitz type |
LAMB3 |
LAMB3 |
3-4 |
junctional, non-Herlitz type |
ITGB4 |
ITGB4 |
2-4 |
junctional, type non-Herlitz |
LAMB3 |
LAMB3 |
3-4 |
NGS |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 |
4-8 |
simplex |
KRT14 |
KRT14 |
3-4 |
simplex |
KRT5 |
KRT5 |
3-4 |
epidermolytic palmoplantar keratoderma |
KRT1 |
KRT1 |
4-8 |
epidermolytic palmoplantar keratoderma |
KRT9 |
KRT9 |
4-8 |
|
PCDH19 |
PCDH19 |
NULL |
|
HCN1 |
HCN1 |
|
|
NTRK2 |
NTRK2 |
4-6 |
|
SLC6A1 |
SLC6A1 |
NULL |
|
CACNA1E |
CACNA1E |
NULL |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
4-6 |
- |
EPOR |
EPOR |
2-4 |
|
|
|
6 |
type 1 |
FZD4 |
FZD4 |
2-4 |
type 4 |
LRP5 |
LRP5 |
3-4 |
Fabry disease |
GLA |
GLA |
3-4 |
Fabry disease |
GLA |
GLA |
2-3 |
factor 10 deficiency |
F10 |
F10 |
2-3 |
factor 13A1 deficiency |
F13A1 |
F13A1 |
4-6 |
factor 7 deficiency |
F7 |
F7 |
4-6 |
familial cerebral cavernous malformation |
PDCD10 |
PDCD10 |
4-5 |
type 3 |
CLDN16 |
CLDN16 |
2-4 |
type 5 |
CLDN19 |
CLDN19 |
2-4 |
- |
BRIP1/FANCJ |
BRIP1/FANCJ |
4-8 |
- |
FANCA |
FANCA |
4-8 |
- |
FANCA |
FANCA |
3-4 |
- |
FANCC |
FANCC |
4-8 |
- |
FANCD1/BRCA2 |
FANCD1/BRCA2 |
4-8 |
- |
FANCI |
FANCI |
4-8 |
hromosomal breakage study |
|
|
2-3 |
NGS |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 |
4-8 |
|
FANCA |
FANCA |
|
|
ASAH1 |
ASAH1 |
2-4 |
|
|
|
|
NGS |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... |
AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI |
4-6 |
|
FGFR2 |
FGFR2 |
4-5 |
|
|
|
|
Floating-Harbor syndrome |
SRCAP |
SRCAP |
4-5 |
|
|
|
4-8 |
|
FMR1 |
FMR1 |
2-5 |
Fragile X syndrome |
FMR1 |
FMR1 |
4-5 |
Frank-Ter Haar syndrome |
SH3PXD2B |
SH3PXD2B |
6-8 |
Friedreich ataxia |
FXN |
FXN |
3-4 |
Friedreich ataxia |
FXN |
FXN |
2-4 |
fructose intolerance |
ALDOB |
ALDOB |
2-4 |
|
SMCHD1 |
SMCHD1 |
|
|
|
|
1-2 |
galactokinase deficiency with cataracts |
GALK1 |
GALK1 |
2-4 |
- |
CTNNA1 |
CTNNA1 |
4-8 |
NGS |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 |
4-8 |
|
GBA |
GBA |
2-3 |
|
ACTL6A |
ACTL6A |
2-4 |
|
SOX3 |
SOX3 |
2-4 |
type 1 |
ENPP1 |
ENPP1 |
2-4 |
generalized pustular psoriasis |
IL36RN |
IL36RN |
3-4 |
|
|
|
NULL |
|
|
|
NULL |
|
|
|
6-10 |
juvenile type |
CTSA |
CTSA |
2-4 |
Gilbert syndrome |
UGT1A1 |
UGT1A1 |
1-2 |
|
|
|
4-6 |
|
BVES |
BVES |
NULL |
glioma |
POT1 |
POT1 |
2-4 |
glioma |
POT1 |
POT1 |
2-4 |
NGS |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 |
4-8 |
glomuvenous malformation |
GLMN |
GLMN |
NULL |
NGS |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 |
4-6 |
glucose/galactose malabsorption |
SLC5A1 |
SLC5A1 |
2-4 |
type I |
GCDH |
GCDH |
8-12 |
glycine amidinotransferase deficiency |
GATM |
GATM |
5-7 |
glycine encephalopathy |
AMT |
AMT |
3-4 |
glycine encephalopathy |
GLDC |
GLDC |
3-4 |
|
RFT1 |
RFT1 |
3-6 |
congenital |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 |
PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, |
4-8 |
congenital |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 |
B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S |
4-8 |
congenital |
MGAT2 |
MGAT2 |
4-8 |
congenital |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 |
ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, |
4-8 |
congenital type 1T |
PGM1 |
PGM1 |
2-4 |
congenital, type 1A |
PMM2 |
PMM2 |
4-8 |
congenital, type 1B |
MPI |
MPI |
2-4 |
congenital, type 2 |
ALG9 |
ALG9 |
2-4 |
type 1-3 |
GLB1 |
GLB1 |
14-16 |
Goltz-Gorlin syndrome |
PORCN |
PORCN |
4-5 |
|
SUFU |
SUFU |
|
|
GLI3 |
GLI3 |
2-3 |
gyrate atrophy of the choroid and retina |
OAT |
OAT |
2-4 |
|
SLC29A3 |
SLC29A3 |
2-4 |
- |
BRAF |
BRAF |
2 |
NGS |
BRAF, KLF2, CDKN1B |
BRAF, KLF2, CDKN1B |
2 |
|
|
|
NULL |
MLPA |
|
|
2-4 |
NGS |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 |
4-8 |
type 1 |
HFE |
HFE |
4-8 |
type 2A |
HFE2/HJV |
HFE2/HJV |
4-8 |
NGS |
|
|
4-6 |
hemophilia A |
F8 |
F8 |
2-3 |
hemophilia A |
F8 |
F8 |
4-5 |
prognostic marker |
ITPA |
ITPA |
NULL |
type 1 |
SLC22A12 |
SLC22A12 |
2-4 |
type 2 |
SLC2A9 |
SLC2A9 |
2-4 |
|
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR |
4-6 |
|
GGCX |
GGCX |
2-4 |
|
|
|
3-5 |
|
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC |
4-6 Wochen |
|
verschiedene Gene für HPS |
verschiedene Gene für HPS |
4-8 |
type 5 |
HPS5 |
HPS5 |
2-4 |
type 6 |
HPS6 |
HPS6 |
2-4 |
type 8 |
BLOC1S3 |
BLOC1S3 |
2-4 |
type 1 |
HPS1 |
HPS1 |
2-4 |
|
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 |
4-8 |
|
EDN3 |
EDN3 |
3-4 |
- |
EDNRB |
EDNRB |
3-4 |
|
verschiedene Gene |
verschiedene Gene |
NULL |
susceptibility/resistance to |
CCR5 |
CCR5 |
2-3 |
NGS |
diverse Gene |
diverse Gene |
4-8 |
NGS |
DICER, FAS, POT1, PTPN11, TP53 |
DICER, FAS, POT1, PTPN11, TP53 |
4-6 |
Hutchinson-Gilford progeria |
LMNA |
LMNA |
3-4 |
|
KYNU |
KYNU |
5-6 |
|
L1CAM |
L1CAM |
3-4 |
Hyper-IgD-Syndrom |
MVK |
MVK |
|
|
SCN4A |
SCN4A |
3-5 |
NGS |
APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 |
APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 |
4-6 |
1 |
GLRA1 |
GLRA1 |
8-20 |
1-3 |
GLRA1, GLRB, SLC6A5 |
GLRA1, GLRB, SLC6A5 |
4-6 |
2 |
GLRB |
GLRB |
8-20 |
3 |
SLC6A5 |
SLC6A5 |
8-12 |
hyperferritinemia |
FTL |
FTL |
4-6 |
hyperferritinemia |
FTL |
FTL |
4-6 |
|
UCP2 |
UCP2 |
2-4 |
type 3 |
APOE |
APOE |
2-3 |
hyperlipoproteinemia |
LPL |
LPL |
2-4 |
hyperostosis corticalis generalisata |
LRP5 |
LRP5 |
3-4 |
|
SLC26A1 |
SLC26A1 |
2-4 |
type 3 |
HOGA1/DHDPSL |
HOGA1/DHDPSL |
2-4 |
|
|
|
4-6 |
|
|
|
2-4 Wochen |
|
TRPV6 |
TRPV6 |
2-4 |
|
PIGV |
PIGV |
NULL |
|
PIGW |
PIGW |
NULL |
type 2 |
ALDH4A1 |
ALDH4A1 |
3-4 |
malignant |
RYR1, CACNA1S, STAC3 |
RYR1, CACNA1S,STAC3 |
4-6 |
|
|
|
4-6 |
Hypoalphalipoproteinemia |
LCAT |
LCAT |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
Hypocalcemia |
CASR |
CASR |
2-4 |
|
COL2A1 |
COL2A1 |
2-3 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondrogenesis |
COL2A1 |
COL2A1 |
4-6 |
hypochondroplasia |
FGFR3 |
FGFR3 |
1-2 |
hypochondroplasia |
FGFR3 |
FGFR3 |
3-4 |
NGS |
|
|
4-6 |
hypomyelinating leukodystrophy-5 |
FAM126A |
FAM126A |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
2 |
hypophosphatasia |
ALPL/TNSALP |
ALPL/TNSALP |
4-6 |
|
SLC9A3R1 |
SLC9A3R1 |
2-4 |
|
|
|
4-6 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
autosomal dominant |
FGF23 |
FGF23 |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
X-linked dominant |
PHEX |
PHEX |
2-4 |
hypoplastic left heart syndrome |
NKX2-5 |
NKX2-5 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
IGF1 deficiency |
IGF1 |
IGF1 |
2-4 |
|
IL3RA |
IL3RA |
2-4 |
immuno deficiency |
IRAK4 |
IRAK4 |
6-8 |
immuno deficiency 47 |
ATP6AP1 |
ATP6AP1 |
4-8 |
immunoglobulin A (IgA) deficiency |
TNFRSF13B |
TNFRSF13B |
4-6 |
Infantile Hypercalciuria |
CYP24A1 |
CYP24A1 |
2-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
infertility, CBAVD |
CFTR |
CFTR |
3-4 |
|
HIVEP2 |
HIVEP2 |
NULL |
|
MBOAT7 |
MBOAT7 |
|
|
CNKSR2 |
CNKSR2 |
NULL |
|
USP9X |
USP9X |
NULL |
|
GRIA3 |
GRIA3 |
NULL |
|
SETD5 |
SETD5 |
NULL |
|
TRAPPC11 |
TRAPPC11 |
|
Interleukin-1 receptor antagonist deficiency |
IL1RN |
IL1RN |
3-5 |
IPEX syndrome |
FOXP3 |
FOXP3 |
2-4 |
Irinotecan Therapy |
UGT1A1 |
UGT1A1 |
2-3 |
|
|
|
|
isovaleric acidemia |
IVD |
IVD |
5-6 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
1-2 |
Jackson-Weiss syndrome |
FGFR2 |
FGFR2 |
3-4 |
JPM syndrome |
PSMB8 |
PSMB8 |
8-12 |
|
CACNB4 |
CACNB4 |
34-35 |
|
CACNG4 |
CACNG4 |
NULL |
|
LDB3 |
LDB3 |
NULL |
|
PLN |
PLN |
NULL |
|
SLC25A3 |
SLC25A3 |
3-4 |
|
CAV3 |
CAV3 |
2-4 |
|
LMNA |
LMNA |
2-4 |
|
TTN |
TTN |
NULL |
3-Hydroxyisobutyrate dehydrogenase deficiency |
HIBADH |
HIBADH |
2-4 |
|
MGP |
MGP |
4-6 |
|
|
|
1-2 |
|
KMT2C |
KMT2C |
NULL |
type 1 |
GDF6 |
GDF6 |
8-20 |
type 3 |
GDF3 |
GDF3 |
8-20 |
Klippel-Feil syndrome 2 |
MEOX1 |
MEOX1 |
8-20 |
type 1 |
COL18A1 |
COL18A1 |
2-4 |
|
CARS2 |
CARS2 |
|
|
ITPR3 |
ITPR3 |
|
|
TUBB |
TUBB |
2-4 |
Krabbe disease |
GALC |
GALC |
6-10 |
L-2-hydroxyglutaric aciduria |
L2HGDH |
L2HGDH |
8-10 |
congenital |
LCT |
LCT |
3-4 |
LARGE associated diseases |
LARGE |
LARGE |
5-6 |
Laron syndrome |
GHR |
GHR |
2-4 |
Laron syndrome |
GHR, IGF1, JAK2, STAT5B |
GHR, IGF1, JAK2, STAT5B |
2-4 |
Larsen syndrome |
FLNB |
FLNB |
2-3 |
Larsen syndrome |
FLNB |
FLNB |
3-4 |
Larsen syndrome |